Cellectis (CLLS) Common Equity (2016 - 2023)
Historic Common Equity for Cellectis (CLLS) over the last 10 years, with Q3 2023 value amounting to $76.1 million.
- Cellectis' Common Equity fell 4772.2% to $76.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $76.1 million, marking a year-over-year decrease of 4772.2%. This contributed to the annual value of $125.9 million for FY2022, which is 4674.21% down from last year.
- As of Q3 2023, Cellectis' Common Equity stood at $76.1 million, which was down 4772.2% from $96.6 million recorded in Q2 2023.
- Over the past 5 years, Cellectis' Common Equity peaked at $432.3 million during Q1 2019, and registered a low of $2.8 million during Q2 2020.
- Its 5-year average for Common Equity is $216.0 million, with a median of $236.5 million in 2021.
- Per our database at Business Quant, Cellectis' Common Equity crashed by 9931.67% in 2020 and then surged by 317759.67% in 2023.
- Over the past 5 years, Cellectis' Common Equity (Quarter) stood at $315.1 million in 2019, then fell by 1.99% to $308.8 million in 2020, then fell by 23.43% to $236.5 million in 2021, then tumbled by 46.74% to $125.9 million in 2022, then tumbled by 39.56% to $76.1 million in 2023.
- Its Common Equity stands at $76.1 million for Q3 2023, versus $96.6 million for Q2 2023 and $120.5 million for Q1 2023.